Prostatic Urethral Lift reimbursed in the Netherlands since 2020

11

Jun 2020

In the Netherlands, Basic Health Insurance is determined/guaranteed by the Health Insurance Law (Zorgverzekeringswet, Zvw). The Law describes care in very general terms, so there is a lack of clarity in many situations regarding what is covered. Dutch Health Care Institute (Zorginstituut Nederland) is responsible for determining the allocation of care under Basic Health Insurance. The position of the Institute is based on an assessment of clinical and economic evidence to determine the conformity of care with a “state of science and practice.”

According to the “Overview of care activities with a claim code” (2020), prostatic urethral lift belongs to the type of care with specific conditions of reimbursement within the basic health insurance and has a claim code “2601”. Prostatic Urethral Lift / Urolift in patients with non-neurogenic symptoms lower urinary tract (LUTS) in benign prostatic hyperplasia (BPH) meets the state of science and practice in the following indications:

  • Patients with non-neurogenic LUTS due to BPH, for whom a prostatectomy is indicated, but the patient wants to maintain ejaculation and erections;
  • Patients who have very debilitating or very limiting side effects of drug treatment of LUTS due to BPH and who wish to be treated using minimally invasive technique;
  • Patients with higher ASA classification (3 or higher) and with non-neurogenic LUTS (with or without catheter), who underwent surgery and for whom the local anesthesia can take place. This is an indication for people who have complaints and who should undergo prostatectomy but cannot have surgery because the risk is too high for that.

To specify the use of the new care activity codes were added in 2020:

  • Transprostatic placement of implants for urethral prostatic obstruction, using an implantation system (036522);
  • Transprostatic implant for the reduction of urethral prostatic obstruction (190680).

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Feb 2022

Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.

Read more

08

Feb 2022

Dutch Healthcare Institute (ZIN) has issued a Pilot Horizon Scan of 39 new diabetes-related MedTech products that are expected on the Dutch market in 2022 or 2023. Patients with diabetes could benefit significantly from the use of these devices. However, available data on their effectiveness and efficiency is limited.

Read more

17

Jan 2022

Dutch Healthcare Authority (NZa) has issued a draft release of the DRG package for 2023, including a new procedure code for intermittent pneumatic compression therapy, a new diagnosis code for guidance in early pregnancy after a fertility program, and several new DRGs for pediatric palliative care, lymphovenous anastomosis surgery and light therapy in inflammatory dermatoses.

Read more

03

Jan 2022

The Dutch Organization for Health Research and Development (ZonMw) will accept applications for subsidies under the "Early Detection" sub-program until March 8, 2022. This scheme is intended for upscaling screening programs or population screening.

Read more